Cytoskeletal remodeling, often characterized by changes in Glial fibrillary acidic protein (GFAP) levels, neuroinflammation, redox balance, lipid and protein metabolism have all been identified to be altered in astrocytes from the AD brain (Viejo et al., 2022). This evidence concerns the gene GFAP and Alzheimer disease.